$KMTS Balance Sheet | Understand Stock

$KMTS

$30.58 +$0.71 (2.38%) Live

$KMTS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q1 FY2027 As of Jul 31, 2026	Q4 FY2026 As of Apr 30, 2026	Q3 FY2026 As of Jan 31, 2026	Q2 FY2026 As of Oct 31, 2025	Q1 FY2026 As of Jul 31, 2025	Q4 FY2025 As of Apr 30, 2025	Q3 FY2025 As of Jan 31, 2025
Assets
Current assets
Cash and cash equivalents
West Affum Intermediate Holdings Corp.
Total cash and cash equivalents
Short-term investments
Accounts receivable, net
West Affum Intermediate Holdings Corp.
Total accounts receivable, net
Disposable medical equipment supplies
West Affum Intermediate Holdings Corp.
Total disposable medical equipment supplies
Prepaid expenses and other current assets
West Affum Intermediate Holdings Corp.
Total prepaid expenses and other current assets
West Affum Intermediate Holdings Corp.
Total current assets
Long-term investments
Right-of-use assets
West Affum Intermediate Holdings Corp.
Total right-of-use assets
Deposits
West Affum Intermediate Holdings Corp.
Total deposits
Restricted cash
West Affum Intermediate Holdings Corp.
Total restricted cash
Property and equipment, net
West Affum Intermediate Holdings Corp.
Total property and equipment, net
Other long-term assets
West Affum Intermediate Holdings Corp.
Total other long-term assets
West Affum Intermediate Holdings Corp.
Total assets
Liabilities and Shareholders' Equity
Current liabilities
Accounts payable
West Affum Intermediate Holdings Corp.
Total accounts payable
Accrued liabilities
West Affum Intermediate Holdings Corp.
Total accrued liabilities
Operating lease liabilities, current portion
West Affum Intermediate Holdings Corp.
Total current liabilities
Operating lease liabilities, net of current portion
West Affum Intermediate Holdings Corp.
Total operating lease liabilities, net of current portion
Warrant liabilities
Other long-term liabilities
West Affum Intermediate Holdings Corp.
Total other long-term liabilities
Long-term debt, net
West Affum Intermediate Holdings Corp.
Total long-term debt, net
Liabilities
West Affum Intermediate Holdings Corp.
Total liabilities
Redeemable preferred stock, $0.01 par value; 0 and 5,000,000 shares authorized as of April 30, 2025 and April 30, 2024, respectively; 0 and 177,110 shares issued and outstanding as of April 30, 2025 and April 30, 2024, respectively
Shareholders' equity
Common Shares, $1.00 par value; 100,000,000 shares authorized as of July 31, 2026 and April 30, 2026; 59,271,885 issued and outstanding as of July 31, 2026 and 58,383,924 shares issued and outstanding as of April 30, 2026
West Affum Intermediate Holdings Corp.
Total common Shares, $1.00 par value; 100,000,000 shares authorized as of July 31, 2026 and April 30, 2026; 59,271,885 issued and outstanding as of July 31, 2026 and 58,383,924 shares issued and outstanding as of April 30, 2026
Additional paid-in capital
West Affum Intermediate Holdings Corp.
Total additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
West Affum Intermediate Holdings Corp.
Total accumulated deficit
Total West Affum Intermediate Holdings Corp. stockholder's deficit
Non-controlling interest
West Affum Intermediate Holdings Corp.
Total shareholders' equity
West Affum Intermediate Holdings Corp.
Total liabilities and shareholders' equity

Comments